Litigation for Cause: MDL 2516 In Re: Aggrenox Antitrust Litigation

✉ Email this page to a colleague

US Court Litigation for Cause: MDL 2516 In Re: Aggrenox Antitrust Litigation

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,015,577	Rite Aid Corporation v. Boehringer Ingelheim Pharma GMBH & Co. KG	⤷ Get Started Free	2015-04-27	2019-03-14	MDL 2516 In Re: Aggrenox Antitrust Litigation	District Court, D. Connecticut	Plaintiff	⤷ Get Started Free
>Patent	>Case Name	>Docket	>Date Filed	>Date Terminated	>Cause	>Court	>Jury Demand	>Link To Docket

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.